JR
Insider selling
John R Stuelpnagel sold $1.2M of 10x Genomics, Inc. (TXG) stock
John R Stuelpnagel, Dir of 10x Genomics, Inc. (TXG), sold 20,000 shares of TXG stock worth $1.2M, per an SEC Form 4 filed Sep 8, 2026.
It was an open-market sale.
The trade happened on Sep 3, 2026, 5 days before it was made public.
TXG has moved +25.1% since the trade date, from $63.22 to $79.10 (Sep 21, 2026 close).
- Traded
- Sep 3, 2026
- Disclosed
- Sep 8, 2026
- Filing delay
- 5 days
- Price since
- +25.1%
- Role
- Dir
- Source
- SEC Form 4
More TXG insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.